What MASAI Answered — Has AI Mammography Surpassed Radiologists? | Reading Breast Cancer Diagnosis with AI, Vol. 1
The MASAI trial, a Swedish randomized study of more than 105,000 women, demonstrated that AI-supported mammography reduces interval breast cancers by 12% while lifting sensitivity to 80.5%. In Volume 1 of our series "Reading Breast Cancer Diagnosis with AI," we unpack what MASAI answered about whether AI replaces physicians or augments them.
